University of Minnesota opens clinical trial for treatment of COVID-19

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The University of Minnesota has begun a clinical study to test whether a novel cell therapy currently under clinical investigation as a treatment for acute myeloid leukemia and lymphoma can be effective as a treatment for COVID-19.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login